Xue‐Yi Xue

2.0k total citations
125 papers, 1.2k citations indexed

About

Xue‐Yi Xue is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Xue‐Yi Xue has authored 125 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Pulmonary and Respiratory Medicine, 37 papers in Surgery and 35 papers in Molecular Biology. Recurrent topics in Xue‐Yi Xue's work include Prostate Cancer Treatment and Research (31 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Ferroptosis and cancer prognosis (21 papers). Xue‐Yi Xue is often cited by papers focused on Prostate Cancer Treatment and Research (31 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Ferroptosis and cancer prognosis (21 papers). Xue‐Yi Xue collaborates with scholars based in China, United States and Hong Kong. Xue‐Yi Xue's co-authors include Ning Xu, Yong Wei, Qing‐Shui Zheng, Shao‐Hao Chen, Yu‐Peng Wu, Zhi‐Bin Ke, Jin‐Bei Huang, Yun‐Zhi Lin, Hai Cai and Xiong‐Lin Sun and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and Oncogene.

In The Last Decade

Xue‐Yi Xue

115 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue‐Yi Xue China 20 587 467 336 246 245 125 1.2k
Kai Yuan China 19 523 0.9× 386 0.8× 302 0.9× 88 0.4× 402 1.6× 66 1.1k
Ashkan Mortezavi Switzerland 19 622 1.1× 263 0.6× 101 0.3× 246 1.0× 127 0.5× 64 1.1k
Gary H. Weiss United States 16 480 0.8× 356 0.8× 307 0.9× 328 1.3× 121 0.5× 32 1.0k
Simone Bertz Germany 25 421 0.7× 648 1.4× 330 1.0× 1.2k 4.7× 247 1.0× 87 1.9k
Orhan G. Yigitbasi Türkiye 18 286 0.5× 303 0.6× 94 0.3× 187 0.8× 95 0.4× 49 982
Koichiro Minami Japan 19 162 0.3× 396 0.8× 287 0.9× 221 0.9× 91 0.4× 46 980
Sertaç Yazıcı Türkiye 18 379 0.6× 459 1.0× 173 0.5× 196 0.8× 65 0.3× 56 1.2k
Sheila F. Faraj United States 22 731 1.2× 330 0.7× 207 0.6× 688 2.8× 87 0.4× 56 1.5k
Giovanna A. Giannico United States 18 271 0.5× 213 0.5× 89 0.3× 184 0.7× 54 0.2× 64 936
Jiao Hu China 18 428 0.7× 556 1.2× 327 1.0× 306 1.2× 55 0.2× 56 1.1k

Countries citing papers authored by Xue‐Yi Xue

Since Specialization
Citations

This map shows the geographic impact of Xue‐Yi Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue‐Yi Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue‐Yi Xue more than expected).

Fields of papers citing papers by Xue‐Yi Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue‐Yi Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue‐Yi Xue. The network helps show where Xue‐Yi Xue may publish in the future.

Co-authorship network of co-authors of Xue‐Yi Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Xue‐Yi Xue. A scholar is included among the top collaborators of Xue‐Yi Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue‐Yi Xue. Xue‐Yi Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Shaoming, Xiaodong Li, Fei Lin, et al.. (2025). Total or partial adrenalectomy for aldosterone-producing adenoma: can 68Ga-Pentixafor PET/CT predict surgical outcomes?. European Journal of Nuclear Medicine and Molecular Imaging. 52(10). 3632–3642. 3 indexed citations
2.
3.
Lin, Fei, Yu‐Peng Wu, Zhi‐Bin Ke, et al.. (2024). Identification of neutrophil extracellular traps (NETs)-related molecular clusters in prostate cancer: Implications for predicting biochemical recurrence. International Immunopharmacology. 146. 113908–113908. 3 indexed citations
4.
5.
Liu, Weihui, et al.. (2024). Construction of an alignment diagram model for predicting calculous obstructive pyonephrosis before PNL. Heliyon. 10(7). e28448–e28448. 1 indexed citations
6.
7.
Kang, Zhen, Dong‐Ning Chen, Qing‐Shui Zheng, et al.. (2024). Identification macrophage signatures in prostate cancer by single-cell sequencing and machine learning. Cancer Immunology Immunotherapy. 73(3). 41–41. 5 indexed citations
8.
Ke, Zhi‐Bin, Qi You, Wenqi Liu, et al.. (2023). Body composition parameters were associated with response to abiraterone acetate and prognosis in patients with metastatic castration‐resistant prostate cancer. Cancer Medicine. 12(7). 8251–8266. 4 indexed citations
9.
Chen, Hang, Jia‐Yin Chen, Shao‐Hao Chen, et al.. (2023). Exploring Novel Genome Instability-associated lncRNAs and theirPotential Function in Pan-Renal Cell Carcinoma. Combinatorial Chemistry & High Throughput Screening. 27(12). 1788–1807. 1 indexed citations
10.
Chen, Ye‐Hui, Hang Chen, Tingting Lin, et al.. (2023). ARPC1A correlates with poor prognosis in prostate cancer and is up-regulated by glutamine metabolism to promote tumor cell migration, invasion and cytoskeletal changes. Cell & Bioscience. 13(1). 38–38. 4 indexed citations
11.
Chen, Lü, Zhi‐Bin Ke, Shao‐Hao Chen, et al.. (2021). Angiogenesis-Related Molecular Subtypes and a Novel Prognostic Signature in Clear Cell Renal Cell Carcinoma Patients. International Journal of General Medicine. Volume 14. 6325–6342. 1 indexed citations
12.
Xu, Ning, Zhi‐Bin Ke, Xiaodan Lin, et al.. (2020). Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysis. Cancer Cell International. 20(1). 302–302. 31 indexed citations
13.
Xu, Ning, Yu‐Peng Wu, Hubin Yin, et al.. (2020). SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis. Journal of Cancer Research and Clinical Oncology. 146(8). 1953–1969. 23 indexed citations
14.
Xu, Ning, Yu‐Peng Wu, Zhi‐Bin Ke, et al.. (2019). Risk factors of developing visceral metastases at diagnosis in prostate cancer patients. Translational Cancer Research. 8(3). 928–938. 3 indexed citations
15.
Xu, Ning, Yu‐Peng Wu, Hubin Yin, Xue‐Yi Xue, & Xin Gou. (2018). Molecular network-based identification of competing endogenous RNAs and mRNA signatures that predict survival in prostate cancer. Journal of Translational Medicine. 16(1). 274–274. 42 indexed citations
16.
Wei, Yong, Yu‐Peng Wu, Shao‐Hao Chen, et al.. (2018). Impact of Obesity on Long-Term Urinary Incontinence after Radical Prostatectomy: A Meta-Analysis. BioMed Research International. 2018. 1–9. 24 indexed citations
17.
Xu, Ning, Yu‐Peng Wu, Xiaodong Li, et al.. (2018). Upregulation of Arp2 expression is associated with the prognosis and prediction of lymph node metastasis in bladder urothelial carcinoma. Cancer Management and Research. Volume 10. 503–511. 5 indexed citations
18.
19.
Wei, Yong, Xiao-Dong Li, Ning Xu, et al.. (2014). [Penile appearance, sexual function and sexual satisfaction of hypospadias patients after surgery: a long-term follow-up study].. PubMed. 20(1). 48–53.
20.
Li, Xiao-Dong, Ning Xu, Xue‐Yi Xue, et al.. (2014). [One-stage nonstented tubularized incised plate urethroplasty for pain and complication after hypospadias repair].. PubMed. 28(12). 1505–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai Yuan Breakdown of academic impact, for papers by Ashkan Mortezavi Breakdown of academic impact, for papers by Gary H. Weiss Breakdown of academic impact, for papers by Simone Bertz Breakdown of academic impact, for papers by Orhan G. Yigitbasi Breakdown of academic impact, for papers by Koichiro Minami Breakdown of academic impact, for papers by Sertaç Yazıcı Breakdown of academic impact, for papers by Sheila F. Faraj Breakdown of academic impact, for papers by Giovanna A. Giannico Breakdown of academic impact, for papers by Jiao Hu
Rankless by CCL
2026